World Acceptance Non-GAAP EPS of $2.12 beats by $1.54, revenue of $139.21M misses by $4.69MJuly 24, 2026
Share Facebook Twitter LinkedIn Pinterest Email Bristol Myers wins FDA approval for Opdivo in first-line Hodgkin lymphoma
World Acceptance Non-GAAP EPS of $2.12 beats by $1.54, revenue of $139.21M misses by $4.69MJuly 24, 2026
